Despite the arrivals of new drugs, Genentech continues to be the market leader. Its drugs, Rituxan, Avastin, and Herceptin, are the category leaders, generating a total of $9.29 billion in sales.
Avanir marketing chief on selling first-in-class therapies
Avanir’s success with Nuedexta sparked the attention of several suitors. In 2014 the company reached a deal to be sold to Otsuka Pharmaceutical for around $3.5 billion
How Should Pharma Deploy Messaging in EHR Systems?
July 13, 2016
2:05 pm
Pharma must be thoughtful in its approach and demonstrate value to be part of the EHR conversation.
Imagine if the agencies pitching us mocha lattes faced these consumer beliefs: The latte will hurt when I drink it. The latte might leave me with a rash or cause me to vomit.